The present disclosure provides systems and method for electric plasma synthesis of nitric oxide. In particular, the present disclosure provides a nitric oxide (NO) generation system configured to produce a controllable output of therapeutic NO gas at the point of care.

A system and method are provided for the separation of hydrogen from natural gas feedstock to form hydrocarbon radicals. Aspects of the system include perpendicular magnetic and electric fields, a method of radical formation that separates hydrogen from the reaction process, and a separation method based on centrifugal forces and phase transitions. The gases rotate in the chamber due to the Lorentz force without any mechanical motion. Rotation separates gases and liquids by centrifugal force. The lighter species are collected from the mid region endpoint of the apparatus and fed back for further reaction. A new concept of controlled turbulence is introduced to mix various species. A novel magnetic field device is introduced comprised of two specially magnetized cylinders. A novel control of temperatures, pressures, electron densities and profiles by, RF, microwaves, UV and rotation frequency are possible especially when atomic, molecular, cyclotron resonances are taken into account. The electrodes can be coated with catalysts; the entire apparatus can be used as a new type of chemical reactor.

A first voltage source produces a first voltage such as an AC voltage. Further, a first electrode of a hydrogen generation system conveys the first voltage. The first voltage conveyed over the first electrode generates low-temperature plasma extending between the first electrode and the mass of material. Presence of the low-temperature plasma releases gas from the mass of material.

A method and apparatus for making carbon black. A plasma gas is flowed into a plasma forming region containing at least one, magnetically isolated, plasma torch containing at least one electrode, and forming a plasma. Collecting the plasma formed in a cooled header and flowing the plasma through at least one reaction region to heat the reaction region, and injecting carbon black forming feedstock into the reaction region, resulting in the formation of at least one grade of carbon black. An apparatus for making carbon black is also described including a plasma forming section containing at least one, magnetically isolated plasma torch containing at least one electrode, in fluid flow communication with at least one carbon black forming reactor section, the plasma section and reactor section separated by a plasma formed collection header.

A device for obtaining and applying a disinfectant agent and method of use are provided. The device includes a pre-processing cascade unit that activates (ionizes) air, with the activated air being supplied by an air pump to an inlet of a sprayer, where the activated air mixes with an initial working fluid (distilled water) to form an activated air-working fluid aerosol mixture that is sprayed by the sprayer into a reactor of cone-shaped volumetric cold plasma that includes divergent discharge electrodes. The device further includes a unit for generating high-voltage pulses of a nanosecond duration that is connected to the discharge electrodes and that causes the electrodes to generate electrical discharges. Upon the mixture coming into contact with the electrical discharges, potent disinfectant agents (such as peroxynitrite and one or more peroxynitrite's precursors or derivatives) are synthesized and expelled from the device.

A system for producing carbonaceous materials is disclosed that includes an energy source configured to emit microwave energy and a plasma reactor coupled to receive the microwave energy and configured to produce plasma in response to exposure of one or more process gases to the microwave energy. In some instances, the plasma reactor includes a first chamber having a rectangular cross-section and configured to receive the microwave energy from the energy source as sinusoidal waveform, a second chamber having a cylindrical cross-section and configured to receive microwave energy from the first chamber as a radial waveform having an energy maxima at a radial center of the cylindrical cross-section, the second chamber including an opening to receive one or more process gases and configured to ignite a plasma plume, and a gas-solid separator configured to separate solid materials from the plasma plume.

This invention relates to a production method for non-detonation synthesis nanodiamond by exposing carbonaceous feedstock to a dense plasma focus. The nucleated nanodiamond particles have characteristics that differentiate them from known forms of nanodiamond. For instance, the nucleated nanodiamond particles are substantially spherical and have a substantially smooth surface, as may be demonstrated by TEM. The nucleated nanodiamond particles are also free of graphite and detonation carbon contaminants. The identity of the nanodiamond particles has been confirmed through raman spectra, for example. The nanodiamond particles have also been found to be effective as a lubricant composition when combined with a carrier oil.

A universal chemical processor (UCP) including a reactor vessel having a central longitudinal axis and main chamber comprises a first inlet port for a main feedstock, a second inlet port for a fluidizing medium and a third inlet port for one or more reactants. The UCP also includes a reactive radioactive chemical processor (R.sup.2CP) that contains a radioactive element positioned extending along the longitudinal axis in the main chamber. In operation, a fluidized bed can be supported in the main chamber when a fluidizing medium and feedstock are supplied to the main chamber through the first and second inlet ports and the radioactive element of the R.sup.2CP emits ionizing radiation that is capable of ionizing feedstock and reactants, inducing chemical reactions, and sterilizing and decomposing any organic materials within a radiation zone.

The invention relates to a process and an apparatus for controlled preparation of octachlorotrisilane from monomeric chlorosilanes, by subjecting the chlorosilanes to a thermal plasma.

A pharmaceutical composition is provided comprising a highly soluble arsenic carbonate and/or bicarbonate compound and which is useful in the treatment of a variety of cancers, including acute promyelocytic leukaemia. The arsenic carbonate and/or bicarbonate salt acts as a solid, and so orally deliverable, improved bioequivalent delivery form of arsenic trioxide IV solutions.